Antitrust Antitrust

EU should learn antitrust lessons for new drug-shortage laws, pharma lobby says

By Lewis Crofts
  • 25 Mar 2021 14:43
  • 25 Mar 2021 14:43
New European Union rules on managing supply shortages shouldn't ignore the lessons learned from antitrust guidance issued at the start of the pandemic to help pharma companies cooperate, a group of generic medicine makers said.

Adrian Van Den Hoven, director general of Medicines for Europe, said primary law, and not just temporary

To view the latest version of this document and thousands of others like it, sign-in to MLex or register for a free trial.

Discover MLex

Stay on top of global regulatory developments


Latest News